Axiom Space will partner with the Wake Forest Institute for Regenerative Medicine (WFIRM) and the RegenMed Development Organization (ReMDO). The company will also lease space in the ReMDO Innovation Accelerator,

The collaboration will “expand the commercial space economy and support biomedical commercial innovations and manufacturing for biomedical applications in low orbit.” The space station developed by the company will sit 250 miles above the surface of the Earth, meaning that the research conducted on the space station “will be free from the constraints of gravity, providing great potential and benefits.”

“This partnership paves the way for an entire commercial industry on board Axiom’s space station that will enable our scientific research teams to advance biomanufacturing to bring new treatments that cannot be developed on Earth and treatments for conditions that affect the human body when exposed to the harsh environment of space travel,” said Dr. Anthony Atala, the director of WFIRM. “We can literally take the regenerative medicine field to a whole new level.”

Read more…